ATM functions as a rheostat of metabolic stress in small-cell lung cancer

Debdatta Halder1, Utsav Sen1, Vrinda Jethalia1,2,3

  • 1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Insights

ATM inhibition disrupts stress-adaptive signaling in small-cell lung cancer (SCLC), leading to ferroptosis. This reveals a new metabolic vulnerability and therapeutic target beyond DNA damage repair in aggressive tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • ATM is crucial for genomic stability but its role in SCLC oncogenic signaling is unclear.
  • SCLC's metabolic landscape and interaction with signaling networks are poorly understood, hindering treatment strategies.

Purpose of the Study:

  • To investigate ATM's role in SCLC oncogenic signaling and metabolic adaptation.
  • To identify novel therapeutic vulnerabilities in SCLC by understanding ATM's function beyond DNA damage repair.

Main Methods:

  • Inhibition of ATM in SCLC models.
  • Analysis of AKT-mTORC1-4EBP1 signaling axis and ATF4/MYC feedback loop.
  • Assessment of reactive oxygen species, glutathione recycling, and ferroptosis.

Main Results:

  • ATM inhibition disrupts the AKT-mTORC1-4EBP1 axis and attenuates ATF4.
  • ATM inhibition perturbs ATF4 and MYC co-regulation, impacting redox homeostasis.
  • ATM inhibition increases ROS, impairs glutathione recycling, and induces ferroptosis in SCLC cells.

Conclusions:

  • ATM regulates adaptive stress responses and metabolic rewiring in SCLC, expanding its known functions.
  • ATM inhibition exposes a critical dependency of SCLC on stress-adaptive signaling, offering therapeutic opportunities.
  • Targeting ATM presents a novel strategy for aggressive SCLC by exploiting its metabolic vulnerabilities.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.4K
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
17.4K